Affimed (NASDAQ: AFMD) reported Q3 EPS of (EUR0.11), EUR0.06 better than the analyst estimate of (EUR0.17). Revenue for the quarter came in at EUR14.9 million versus the consensus estimate of EUR6.4 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.